Payam Javan: Several hospitals in the United States have halted the administration of hormone treatments to transgender minors following a directive issued during the Trump administration. The move comes as several institutions reassess their medical protocols for gender-affirming care in light of the recent order, which critics claim has sparked uncertainty among healthcare providers. Hospital officials stated that the temporary suspension is a precautionary measure while they review current practices and regulatory guidelines related to the treatment of children seeking hormone therapy.

Advocacy groups and some medical experts have voiced strong concerns over the decision, arguing that denying or delaying access to hormone treatments could adversely affect the physical and mental well-being of transgender youth. Critics contend that the policy change appears to be politically motivated rather than based on sound medical judgment, emphasizing that decisions about gender-affirming care should remain in the hands of qualified healthcare professionals and the families involved. The development has intensified the national debate over the role of government in medical decision-making and the rights of transgender individuals.